All In MedTech

Device Trial Radar · NCT02577120

Wound Healing Endpoint and Recurrence

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 106 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

106

Actual

Start

Jan 8, 2019

Primary completion

May 31, 2023

Study completion Dec 16, 2025

Sponsor

Lead sponsor
Sashwati RoyAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 16, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a continuation of a previously approved protocol conducted at Ohio State University and Indiana University. The first two aims of the original protocol have been completed, and this protocol will finish enrollment for the third aim, comparing Hi TEWL and Low TEWL measurements, and whether a HiTEWLmeasurement indicates a seemingly healed wound is more likely to recur/reopen toa new wound. Of the 105 desired subjects, 62 subjects have already been recruited and completed their study participation at the previous university. 43 additional subjects will be recruited to complete the enrollment goal here at the University of Pittsburgh.

Conditions

  • Chronic Wound
  • Burn Wound
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Chronic
  • Wound

Interventions

  • Epiceram Skin Barrier FunctionDevice

    Epiceram is a non-sterile, viscous, lipid-rich emulsion

  • Vaseline Petroleum JellyBiological

    A skin protectant used for temporarily protecting minor cuts, scraps, burns, and helps to protect and help relieve chapped or cracked skin and lips.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. TEWLTime frame: 12 weeks

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of Pittsburgh / McKeesport Clinic

    Pittsburgh, Pennsylvania

  • University of Pittsburgh / Mercy Clinic

    Pittsburgh, Pennsylvania

  • University of Pittsburgh / Passavant

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.